Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune

Esat Erdem Türemen1, Berrin Çetinarslan, Tayfun Şahin

  • 1Department of Endocrinology and Metabolism, Kocaeli University, 41110, Turkey. eturemen@gmail.com

Endocrine Journal
|April 15, 2011
PubMed

Insights

Subclinical hypothyroidism is linked to endothelial dysfunction and chronic inflammation, impacting cardiovascular health. These findings suggest inflammation may contribute to vascular issues in patients with subclinical hypothyroidism.

Area of Science:

  • Cardiology
  • Endocrinology
  • Immunology

Background:

  • Subclinical hypothyroidism (SH) is a growing concern for cardiovascular disease (CVD).
  • Controversy exists regarding SH's cardiovascular impact and optimal management.
  • Atherosclerosis precursors like endothelial dysfunction and inflammation are investigated in SH.

Purpose of the Study:

  • To investigate endothelial dysfunction and inflammation in subclinical hypothyroidism.
  • To compare vascular responses between SH patients and healthy controls.
  • To explore correlations between inflammatory markers, lipid profiles, and vascular function in SH.

Main Methods:

  • Recruited 37 SH patients and 23 healthy volunteers.
  • Assessed endothelial function via flow-mediated dilation (FMD) and nitroglycerin (NTG) response.
  • Measured serum inflammatory markers (TNF-alpha, IL-6, hs-CRP) and calculated HOMA scores for insulin resistance.

Main Results:

  • SH patients exhibited significantly impaired endothelium-dependent (FMD) and endothelium-independent (NTG) vascular responses compared to controls.
  • Elevated TSH, LDL, IL-6, TNF-alpha, and hs-CRP levels were observed in the SH group.
  • Endothelium-dependent vasodilation correlated positively with inflammatory markers, TSH, and lipid parameters.

Conclusions:

  • Endothelial dysfunction is present in subclinical hypothyroidism.
  • Low-grade chronic inflammation may be a significant contributor to endothelial dysfunction in SH.
  • Findings suggest autoimmune thyroiditis-related inflammation impacts vascular health in SH.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...